Skip to content

Tender notice

NHS Framework Agreement, Branded Medicines for London and South of England and Bevacizumab for North of England and Midlands and East

Notice details

Published
Category
goods
Buyer region
North West

Public buyer

Public buyer

NHS England

Tender value£441,994,547

  1. Planned start
    As published in the notice
  2. Planned end
    As published in the notice

Work description

Invitation to offer for NHS Framework Agreement, Branded Medicines for London and South of England. Offer ref number: CM/PHR/20/5598 Lot 01 - LONDON Branded Medicines - Tranche B. Period of Framework 01/09/21 - 31/08/23 with option to extend for a period of 24 months. Lot 02 - LONDON Branded Medicines - Annual Tranche. Period of framework 01/09/21 - 31/08/22 with option to extend for period of 12 months. Lot 03 - SOUTH of England Tranche A. Period of Framework: 01/09/21 - 31/08/23 with option for a period of 24 months Lot 04- SOUTH of England - Tranche B. Period of framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 05 - SOUTH of England Annual Tranche. Period of Framework:01/09/21 - 31/08/22 with option to extend for a period of 12 months. Lot 06 - Mids & East and North of England Regions - Bevacizumab. Period of Framework: 01/09/21 - 28/02/22 with option to extend for a period of 6 months.

Related awards

Source: Contracts Finder · Notice 4059a678-516a-48ce-b80a-37abad223085-434729

View source notice